Cite
HARVARD Citation
McClung, M. et al. (n.d.). OP0251 Effects of 2 Years of Treatment with Romosozumab Followed by 1 Year of Denosumab or Placebo in Postmenopausal Women with Low Bone Mineral Density. Annals of the rheumatic diseases. pp. 166-167. [Online].